John Tchelingerian
Chief Executive Officer and Director
Biosciences
Promethra biosciences
Belgium
Biography
Dr. John Tchelingerian, Ph.D. has been the Chief Executive Officer of PROMETHERA Biosciences S.A./N.V., since September 23, 2015. Dr. Tchelingerian serves as the President of Key Neurosciences. He serves as Chairman and President of Diatos USA, Inc. He serves as Chief Executive Officer and President of Diatos S.A. He is a well-recognized serial entrepreneur in the life sciences with scientific, clinical, deal-making and management experience. He served as an Advisor of Kurma Partners. He managed as Chairman and Chief Executive Officer for over nine years at Diatos. He co-founded three biotech companies which includes Neurotech, Key-Obs and Oncobel. In 2009, he co-founded Silver Ocean Ventures. He invented as a scientist several patents in the field of cell therapy and drug delivery. He served as the Chairman of the Board at PROMETHERA Biosciences S.A./N.V., since December 8, 2014 until June 13, 2016. He has been Director of PROMETHERA Biosciences S.A./N.V., since December 8, 2014. Dr. Tchelingerian received his Ph.D in Neurosciences from Pierre et Marie Curie University in Paris and has a dual French and American culture.
Research Interest
Dr. John Tchelingerian, is expertise in Bioscience filed.
